D. H. Johnson

550 total citations
15 papers, 434 citations indexed

About

D. H. Johnson is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Physiology. According to data from OpenAlex, D. H. Johnson has authored 15 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 3 papers in Physiology. Recurrent topics in D. H. Johnson's work include Cancer Treatment and Pharmacology (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Diet and metabolism studies (3 papers). D. H. Johnson is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Diet and metabolism studies (3 papers). D. H. Johnson collaborates with scholars based in United States. D. H. Johnson's co-authors include J. Grayson, Herbert I. Hurwitz, Andrea Podolsky, John W. Severinghaus, Marlowe W. Eldridge, S. S. Kurdak, Philip E. Bickler, John Feiner, Bruno Grassi and D. R. Knight and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Physiology and Journal of Applied Physiology.

In The Last Decade

D. H. Johnson

14 papers receiving 394 citations

Peers

D. H. Johnson
Elaine Drobny United States
Cindy Blifeld United States
M. David Goodman United States
Gabriel Spergel United States
Severo Campione Italy
R Casamitjana Spain
Jiaze Hong China
J. J. Connon Canada
Yasuhiko Matsu-ura Japan
Peter Ciraolo United States
Elaine Drobny United States
D. H. Johnson
Citations per year, relative to D. H. Johnson D. H. Johnson (= 1×) peers Elaine Drobny

Countries citing papers authored by D. H. Johnson

Since Specialization
Citations

This map shows the geographic impact of D. H. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. H. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. H. Johnson more than expected).

Fields of papers citing papers by D. H. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. H. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. H. Johnson. The network helps show where D. H. Johnson may publish in the future.

Co-authorship network of co-authors of D. H. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of D. H. Johnson. A scholar is included among the top collaborators of D. H. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. H. Johnson. D. H. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Karp, Daniel D., et al.. (2010). A phase III, intergroup, randomized, double-blind, chemoprevention trial of selenium (Se) supplementation in resected stage I non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 28(18_suppl). CRA7004–CRA7004. 9 indexed citations
2.
Hurwitz, Herbert I., Pamela S. Douglas, G. W. Sledge, et al.. (2010). Analysis of early hypertension (HTN) and clinical outcome with bevacizumab (BV).. Journal of Clinical Oncology. 28(15_suppl). 3039–3039. 39 indexed citations
3.
Skillings, Jamey, D. H. Johnson, Kathy D. Miller, et al.. (2005). Arterial thromboembolic events (ATEs) in a pooled analysis of 5 randomized, controlled trials (RCTs) of bevacizumab (BV) with chemotherapy. Journal of Clinical Oncology. 23(16_suppl). 3019–3019. 73 indexed citations
4.
5.
Herbst, Roy S., Diane Prager, Róbert Hermann, et al.. (2004). TRIBUTE - A phase III trial of erlotinib HCl (OSI-774) combined with carboplatin and paclitaxel (CP) chemotherapy in advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 22(14_suppl). 7011–7011. 40 indexed citations
6.
Loehrer, Patrick J., W. Wang, Seena C. Aisner, et al.. (2004). Long-term follow-up of patients with locally advanced or metastatic thymic malignancies: The Eastern Cooperative Oncology Group (ECOG) experience. Journal of Clinical Oncology. 22(14_suppl). 7050–7050. 2 indexed citations
7.
Aisner, Seena C., Meera Hameed, W. Wang, et al.. (2004). EGFR and C-Kit immunostaining in advanced or recurrent thymic epithelial neoplasms staged according to the WHO: An Eastern Cooperative Oncology Group Study. Journal of Clinical Oncology. 22(14_suppl). 9637–9637. 1 indexed citations
8.
Tester, William, Patricia Stephenson, Corey J. Langer, et al.. (2004). ECOG 1599: Randomized phase II study of paclitaxel/carboplatin or gemcitabine/cisplatin in performance status (PS) 2 patients with advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 22(14_suppl). 7055–7055. 1 indexed citations
9.
Blanke, Charles D., H. Choy, Ming Teng, et al.. (1999). Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancer.. PubMed. 9(2 Suppl 1). 43–52. 20 indexed citations
10.
Podolsky, Andrea, Marlowe W. Eldridge, R. S. Richardson, et al.. (1996). Exercise-induced VA/Q inequality in subjects with prior high-altitude pulmonary edema. Journal of Applied Physiology. 81(2). 922–932. 66 indexed citations
11.
Eldridge, Marlowe W., Andrea Podolsky, Russell S. Richardson, et al.. (1996). Pulmonary hemodynamic response to exercise in subjects with prior high-altitude pulmonary edema. Journal of Applied Physiology. 81(2). 911–921. 97 indexed citations
12.
Johnson, D. H.. (1954). The effect of haemorrhage and hypotension on the liver blood flow. The Journal of Physiology. 126(3). 413–433. 31 indexed citations
13.
Robinson, Harry J., et al.. (1953). Effect of Adrenocorticotropic Hormone on Pneumococcal Infections in Rabbits. Experimental Biology and Medicine. 83(4). 790–792. 2 indexed citations
14.
Grayson, J. & D. H. Johnson. (1953). The effect of adrenaline and noradrenaline on the liver blood flow. The Journal of Physiology. 120(1-2). 73–94. 40 indexed citations
15.
Grayson, J. & D. H. Johnson. (1952). L-Noradrenaline as Vasoconstrictor. BMJ. 1(4757). 546–547. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elaine Drobny Breakdown of academic impact, for papers by Cindy Blifeld Breakdown of academic impact, for papers by M. David Goodman Breakdown of academic impact, for papers by Gabriel Spergel Breakdown of academic impact, for papers by Severo Campione Breakdown of academic impact, for papers by R Casamitjana Breakdown of academic impact, for papers by Jiaze Hong Breakdown of academic impact, for papers by J. J. Connon Breakdown of academic impact, for papers by Yasuhiko Matsu-ura Breakdown of academic impact, for papers by Peter Ciraolo
Rankless by CCL
2026